3016767
print

Anti-Phospholipase A2 Receptor (PLA2R) Antibody, IgG by ELISA

ANTI-PLA2R
Example Reports
Negative
Positive

Ordering Recommendation

Useful to diagnose primary membranous nephropathy (PMN) and distinguish from secondary nephrotic syndrome. Semiquantitative measurement of PLA2R antibody levels by ELISA is suggested to monitor response over time in individuals undergoing treatment for membranous nephropathy.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Separate serum from cells ASAP or within 2 hours of collection.

Collect

Serum separator tube.

Specimen Preparation

Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Contaminated, heat-inactivated, grossly hemolyzed, grossly icteric, or grossly lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 2 weeks

Methodology

Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)

Performed

Mon, Wed, Thu, Fri

Reported

1-4 days

Reference Interval

Test Number
 Components
 Reference Interval
  Anti-Phospholipase A2 Receptor, IgG < 14 RU/mL

Interpretive Data

A positive anti-phospholipase A2 receptor (PLA2R) antibody result by ELISA or IFA in conjunction with clinical symptoms and other laboratory findings is suggestive of primary membranous nephropathy (pMN). Absence of circulating anti-PLA2R receptor autoantibodies does not rule out a diagnosis of pMN. Anti-PLA2R antibody titers, due to its high predictive value, can be useful for assessing disease severity and monitoring clinical remission. In patients with pMN undergoing treatment, low antibody titers are associated with disease remission and high titers indicate loss of kidney function and need for an aggressive therapeutic approach.


Component
 Interpretive Data
Anti-Phospholipase A2 Receptor, IgG Negative:       Less than 14 RU/mL
Borderline:     14-19 RU/mL
Positive:         Greater than or equal to 20 RU/mL

Compliance Category

FDA

Note

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
09/27/2023
X
N/A

CPT Codes

83516

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
3016768 Anti-Phospholipase A2 Receptor, IgG 73737-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • PLA2R
Anti-Phospholipase A2 Receptor (PLA2R) Antibody, IgG by ELISA